The cancer treatment industry, also known as oncology, is a massive $242 billion industry that is projected to double to $500 billion in the next decade. However, behind the staggering profits lies a disturbing reality of corruption and conflicts of interest.
Conflicts of Interest in Cancer Treatment Guidelines
A recent study found that an alarming 85% of experts who write cancer treatment guidelines received money directly from pharmaceutical companies. This creates a significant conflict of interest, as their income is tied to the treatments they recommend, such as chemotherapy and other drugs.
The Possibility of Suppressed Cancer Cures
It is alleged that multiple cures for cancer may exist, derived from natural compounds found in plants. These treatments could potentially have zero side effects and require no inpatient care. However, if such cures were widely available, the oncology industry would face a catastrophic financial collapse.
The Role of Cancer Research Organizations
Questions arise about the true purpose of cancer research organizations and the donated funds they receive. If a cure for cancer is discovered, there is no legal obligation for these organizations to release it. Instead, there may be a massive incentive to suppress such findings.
Blocking Patents and FDA Approval
Even if a hypothetical study from the New England Journal of Medicine found a treatment with 100% remission of tumors and no side effects, it would still need to go through the lengthy FDA approval process and clinical trials. Furthermore, pharmaceutical companies employ “blocking patents” to prevent other companies from making, using, or selling an invention that infringes on their patent, effectively suppressing potential cures.
The Real-World Survival Rates of Chemotherapy
A PUBG study revealed that the real-world survival rate for colon cancer and late-stage cancer with chemotherapy is only about 34.3%. Moreover, patients undergoing chemotherapy often experience a range of severe side effects.
Interesting Fact: The global oncology market is expected to reach $394.24 billion by 2027, driven by factors such as the increasing prevalence of cancer, the development of novel therapies, and the growing demand for personalized medicine.
Addressing Inaccuracies and Misleading Information
While the video raises important questions about conflicts of interest and the potential suppression of cancer cures, it is crucial to approach these claims with caution. It is important to note that the process of developing and approving cancer treatments is complex and involves rigorous scientific research and testing. The FDA approval process and clinical trials are designed to ensure the safety and efficacy of new treatments before they are made available to the public.
